Keyphrases
Clinical Trials
53%
Clinical Trial Registry
49%
Patient Outcomes
48%
Stroke Trials
45%
Core Outcome Set
45%
Lenvatinib
45%
Nephrology
45%
Reporting Guidelines
45%
Risk Outcomes
45%
Risk-benefit
45%
Patient Benefit
45%
Drug Development
45%
Patient Risk
45%
FDA-approved Drugs
28%
Randomized Controlled Trial
22%
Web-based Survey
22%
Clinical Perspective
22%
Sectional Analysis
22%
Adverse Events
15%
Patient-reported Outcomes
13%
PRISMA
12%
Research Quality
10%
STROBE
9%
Trial Characteristics
9%
Clinical Trial Results
9%
Novel Indications
8%
Progression-free Survival
8%
Overall Survival
8%
Approved Indication
8%
Objective Response Rate
8%
Trialists
8%
Multiphysics Object-oriented Simulation Environment (MOOSE)
6%
Patient-centered
6%
PRISMA-P
6%
High-quality Research
6%
Non-randomized Clinical Trial
6%
PubMed
6%
Drug Efficacy
6%
Clinical Trial Participant
6%
Survival Response
6%
Solid Cancer
6%
Cochrane
6%
Embase
6%
MEDLINE
6%
FDA Indications
6%
Adverse Event Data
6%
Adult Participants
6%
Solid Tumors
6%
CiteScore
5%
Journal Editors
5%
Medicine and Dentistry
Clinical Trial
100%
Systematic Review
48%
Apoplexy
45%
Nephrology
45%
Randomized Controlled Trial
22%
Lenvatinib
22%
Cross Sectional Study
22%
Patient-Reported Outcome
9%
Adverse Event
7%
Mesoglycan
6%
Clinical Trial Results
6%
Clinician
5%
